Tomas Mlcoch (Tomáš Mlčoch)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Pulmonary Arterial Hypertension

Mesenchymal Stem Cells

Rheumatoid Arthritis Patients

Top Venues

Applied health economics and health policy

Expert review of pharmacoeconomics & outcomes research

Expert opinion on biological therapy

Value outcomes s.r.o.

University of Economics Prague (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Value outcomes s.r.o.

Czechia

Health Economy Analyst

Institute of Health Economics and Technology Assessment

Czechia

Health Economy Analyst

Education History

University of Economics Prague

Czechia

MSC :: Department of Economics

Publications

Eva Ornstová, Jan Tuzil, Kateřina Chadimová, Tomas Mlcoch, Tomáš Doležal
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension. Expert review of pharmacoeconomics & outcomes research 22 (8) (2022)
Tomas Mlcoch, Barbora Decker, Tomas Dolezal
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease. Applied health economics and health policy 19 (4) (2021)
Jan Tuzil, Tomas Mlcoch, Jitka Jirčíková, Jakub Závada, Lucie Nekvindová, Michal Svoboda, Michal Uher, Zlatuše Křístková, Jiri Vencovsky, Karel Pavelka, Tomáš Doležal
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry. Expert opinion on biological therapy 20 (2) (2019)
Tomas Mlcoch, Jan Tuzil, Liliana Sedova, Jiri Stolfa, Monika Urbanova, David Suchy, Andrea Smrzova, Jitka Jircikova, Tereza Hrnciarova, Karel Pavelka, Tomas Dolezal
Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis. The patient 11 (3) (2018)